Please use this identifier to cite or link to this item:
Title: Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda
Author: Combalia, Andrea
To i Figueras, Jordi
Laguno Centeno, Montserrat
Martínez Rebollar, María
Aguilera, Paula
Keywords: Hepatitis C
Hepatitis C
Issue Date: 29-Mar-2017
Publisher: Wiley
Abstract: Sporadic porphyria cutanea tarda (PCT) is strongly associated with hepatitis C virus (HCV) infection in our population. 1-4 Therapeutic options for PCT include phlebotomies and low-dose 4-aminoquinolines, which show high rates of disease remission. However, some patients with PCT may present frequent relapses attributable to resistance, intolerability or poor adherence to conventional treatments and/or persistence of risk factors. In 2014, we reported the first case of a patient with active PCT and HCV-HIV coinfection cured with direct antiviral agents (DAAs).5 Herein, we present a cohort of patients demonstrating rapid and persistent remission of PCT with DAA regimes administered for HCV infection.
Note: Versió postprint del document publicat a:
It is part of: British Journal of Dermatology, 2017, vol. 177, num. 5, p. e183-e184
Related resource:
ISSN: 0007-0963
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
672798.pdf708.32 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.